What starts here changes the world
The unique and innovative iQ Group Global business model is transforming the biotechnology industry worldwide.
Our life science and pharmaceutical practice collaborate with scientists the world over: Identifying and owning Intellectual Property, creating and executing drug development plans from discovery to market. From simple chemical entities to complex genetic therapeutics and beyond, we are creating the medicines of the future.
Our dedicated investment banking business transforms biotech from an alternative investment option to a requisite mainstream capital market asset. We design and market innovative structured financial products and solutions. These provide entry and exit, investment and divestment, in the 12 or more year drug development cycle.
In this way the iQ Group Global is
bridging capital with science to create the
medicines of the future.
The life science and pharmaceutical practice provides scientific expertise in areas ranging from biotech IP asset management, medical/clinical research, regulatory and reimbursement strategy, medical affairs and pharmaceutical sales.
The investment banking business provides venture capital, structured financial products, fund management (iQ Series 8) and investment banking on a global scale.
Converging the global investment and scientific community, The iQ Group Global plays a pivotal role in the evolution of the biotech sector, positioning us as the ideal strategic partner for financial market participants, governments, research institutes and the broader biopharma community.